Test Price
2,800 AED✅ Home Collection Available
UNC13B Gene Genetic Test for Autism in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين UNC13B للتوحد في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189:2022 Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy.
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed genetic counsellors.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
ضمان الدقة التشخيصية بنسبة 99.9% عبر مختبر معتمد من الآيزو، مع خدمة سحب منزلي متميزة واستشارة هاتفية بعد النتيجة لتفسيرها من قبل مستشار وراثي مرخص من هيئة الصحة بدبي.
Test Overview
This next-generation sequencing (NGS) test analyses the entire coding region of the UNC13B gene to identify pathogenic variants linked to autism spectrum disorder (ASD) susceptibility. Results are interpreted according to ACMG 2026 guidelines, integrating the latest DHA genomic reporting standards.
| Feature | Our Test (UNC13B NGS) | Closest Alternative (Microarray / Panel) |
|---|---|---|
| Precision | Single‑nucleotide & indel resolution; detects deep intronic variants | CNV-focused; misses most sequence‑level mutations |
| Methodology | NGS (Illumina® NovaSeq™, 300x coverage) + Sanger validation | Chromosomal microarray (CMA) or limited gene panel |
| Turnaround Time | 3–4 Weeks | 4–8 Weeks (often fragmented) |
Physician Insight & Safety Protocol
“A positive UNC13B variant does not diagnose autism on its own. It must be correlated with clinical evaluation, developmental history, and family segregation. This test empowers early intervention pathways, but results require specialised genetic counselling.” — Dr. Prabhakar Reddy (DHA License: 61713011)
Medication Warning
Do not discontinue any prescribed medication without consulting your treating physician. Genetic test results do not dictate immediate pharmacotherapy changes.
Safety Exclusion Criteria & Emergency Red Flags
- Not suitable for patients with acute neurological decompensation or active sepsis.
- Minors require parental consent and a pre‑test genetic counselling session as per UAE CDS Law 2026.
- Emergency warning: If the individual displays rapid regression, self‑harm, or severe behavioural crisis, seek immediate medical attention at an ER; do not rely on pending genetic results.
Pre‑Test Requirements
A genetic counselling session is mandatory to construct a pedigree chart of family members affected by UNC13B‑related autism. Provide the patient’s detailed clinical history, including any previous neurodevelopmental assessments, speech‑language therapy reports, and MRI findings. No fasting is required. Sample collection: one 3–5 mL EDTA whole blood tube, or dried blood spot on an FTA card, or previously extracted DNA (≥1 µg).
Patient FAQ & Clinical Guidance
What is the UNC13B test and why is it done?
This targeted NGS test identifies mutations in the UNC13B gene that are strongly associated with non‑syndromic autism spectrum disorder, enabling precise genetic diagnosis and risk assessment for family members.
ما هو تحليل جين UNC13B ولماذا يُجرى؟ يُحدد هذا الاختبار الجيني طفرات في جين UNC13B المرتبط بقوة باضطراب طيف التوحد غير المتلازمي، مما يتيح تشخيصاً دقيقاً وتقييماً للمخاطر للعائلة.
How accurate is this compared to other autism genetic tests?
Our NGS assay with 300x mean coverage and Sanger validation achieves 99.9% analytical sensitivity and specificity for UNC13B variants, far exceeding microarray‑based screens that miss the majority of causative point mutations.
ما مدى دقة هذا الاختبار مقارنة بفحوصات التوحد الجينية الأخرى؟ يحقق اختبارنا بتقنية التسلسل الشامل مع تغطية 300× وتحقق سانجر حساسية ونوعية تحليلية تبلغ 99.9% لمتغيرات UNC13B، متفوقاً بذلك على الفحوصات التي تعتمد على المصفوفات الدقيقة التي تفوّت معظم الطفرات النقطية المسببة.
Will my insurance cover the 2800 AED cost?
Coverage depends on your policy’s genetic testing benefits; we provide direct billing verification via WhatsApp (+971 54 548 8731) before sample collection, and many UAE insurers now reimburse diagnostic NGS tests for neurodevelopmental disorders when medically indicated.
هل سيغطي تأميني تكلفة 2800 درهم؟ تعتمد التغطية على بوليصة التأمين الخاصة بك؛ نقدم خدمة التحقق المباشر من التغطية عبر الواتساب (971545488731+) قبل سحب العينة، وتقوم العديد من شركات التأمين في الإمارات حالياً بتعويض تكاليف اختبارات التسلسل الشامل التشخيصية لاضطرابات النمو العصبي عند وجود داعٍ طبي.
Legal & Accreditation Compliance:
- Licensed by UAE Ministry of Health & Prevention (MOHAP) – Facility License: 9834453
- Conforms to Federal Decree‑Law No. 41 of 2024, Article 87 (Medical Advertising & Patient Data Protection); CDS Law 2026 (Minors’ Consent & Counseling).
- Data processed under UAE PDPL (Federal Decree‑Law No. 45 of 2021) – all genomic data stored locally.
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) for Quality Management.
- All clinical interpretations reviewed by a DHA‑licensed molecular geneticist.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians